The Diabetic Kidney
Although diabetic kidney disease is the most prevalent cause of end-stage renal disease and the disease most often leading to chronic renal replacement therapy and kidney transplantation, there has been, in recent years, a steady increase in basic and clinical knowledge of the problem. In The Diabet...
Autor Corporativo: | |
---|---|
Otros Autores: | , |
Formato: | Libro electrónico |
Idioma: | Inglés |
Publicado: |
Totowa, NJ :
Humana Press
2006.
|
Colección: | Contemporary Diabetes.
Springer eBooks. |
Acceso en línea: | Conectar con la versión electrónica |
Ver en Universidad de Navarra: | https://innopac.unav.es/record=b32868741*spi |
Tabla de Contenidos:
- Basic Pathophysiology and Biochemistry of Diabetic Nephropathy
- Angiotensin II and Its Receptors in the Pathogenesis of Diabetic Nephropathy
- Altered Renal Microvascular Function in Early Diabetes
- Proteinuria and Interstitial Fibrogenesis in Diabetic Nephropathy
- Podocytes and Diabetic Nephropathy
- Altered Glucose Transport and Its Metabolic Effects in Glomerular Cells
- mRNA Translation in Diabetic Nephropathy
- The Hexosamine Biosynthesis Pathway
- Glycation
- Oxidative and Glycooxidative Stress in Diabetic Nephropathy
- Connective Tissue Growth Factor in the Pathogenesis of Diabetic Nephropathy
- Vascular Endothelial Growth Factor as a Determinant of Diabetic Nephropathy
- Transforming Growth Factor-? Signal Transduction in the Pathogenesis of Diabetic Nephropathy
- Hepatocyte Growth Factor
- Proteomics in the Investigation of Diabetic Nephropathy
- Gene Expression Profiling in the Investigation of Diabetic Nephropathy
- PPAR-? Ligands and Diabetic Nephropathy
- ?-Endosulfine in Diabetic Nephropathy
- The Prospect of a Novel Therapeutic, Bone Morphogenetic Protein-7, in Diabetic Nephropathy
- Clinical Aspects of Diabetic Nephropathy
- Genetic Determinants of Diabetic Nephropathy in Type 2 Diabetes
- Major Risks Indicators for Diabetic Kidney Disease
- The Structure of Human Diabetic Nephropathy
- Diabetic Kidney Disease in Transitional and Disadvantaged Populations
- Screening and Treatment of Early Diabetic Renal Disease in Type 1 and Type 2 Diabetes
- Treatment in Advanced Renal Disease in Type 1 and Type 2 Diabetes
- Diabetic Renal and Related Heart Disease
- Management of Diabetic End-Stage Renal Disease With Dialysis
- Diabetic Retinopathy and Nephropathy
- Hypertension and Cardiovascular Disease
- Endothelial Dysfunction
- Anemia and Diabetic Nephropathy.